SIM
INSY

Spark Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Spark Investment Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-47,500
Closed -$436K – 946
2016
Q4 		$436K Buy
+47,500
New +$537K 0.04% 508
2014
Q2 		– Sell
-11,200
Closed -$231K – 792
2014
Q1 		$231K Sell
11,200
-30,776
-73% -$610K 0.04% 496
2013
Q4 		$541K Sell
41,976
-27,024
-39% -$375K 0.09% 325
2013
Q3 		$803K Buy
+69,000
New +$566K 0.18% 172

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Spark Investment Management's INSY Position: Q1 2017 in Review

Spark Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q1 2017, closing a stake of 47,500 shares — an estimated $436K sold.

Spark Investment Management first reported a position in INSY in Q3 2013 and held it in 4 quarters. The position peaked at $803K in Q3 2013. 116 funds tracked by Wall St. Rank hold INSY as of Q1 2017.

  • Spark Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Spark Investment Management sold 47,500 Insys Therapeutics, Inc. shares in Q1 2017, an estimated $436K.
  • Spark Investment Management first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 4 quarters.
  • Spark Investment Management's Insys Therapeutics, Inc. position peaked at $803K in Q3 2013.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2017.

Based on Spark Investment Management's 13F filing for Q1 2017, filed 11 May 2017.